Generation Bio Company
Generation Bio develops a breakthrough class of genetic medicines based on its proprietary GeneWave technology.
Connections from
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
$10M to $50M
Technology:
Rare Genetic Disorders
Founded Date:
2016
Industry:
Gene Therapy